Viking Therapeutics Inc (NASDAQ:VKTX)

Delayed Data
As of 4:13pm ET
 -0.15 / -2.44%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 18.00, with a high estimate of 40.00 and a low estimate of 12.00. The median estimate represents a +200.00% increase from the last price of 6.00.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Viking Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.00%
Growthannually -51.30%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.